Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphoma. [electronic resource]
Producer: 20000713Description: 773-9 p. digitalISSN:- 0732-183X
- Adult
- Aged
- Antibiotics, Antineoplastic -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Chi-Square Distribution
- Disease Progression
- Female
- Follow-Up Studies
- Humans
- Idarubicin -- administration & dosage
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
- Linear Models
- Lymphoma, Follicular -- drug therapy
- Lymphoma, Mantle-Cell -- drug therapy
- Male
- Middle Aged
- Neoplasm Staging
- Remission Induction
- Survival Rate
- Vidarabine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.